3rd Annual Companion Diagnostics (CDx) Summit Oncology & Beyond: Clinical Applications, Regulation, & Reimbursement

We are pleased to invite you to the “3rd Annual Summit Companion Diagnostics (CDx) in Oncology & Beyond: Clinical Applications, Regulation, & Reimbursement” scheduled for October 26th - 27th, 2017 in Vienna, Austria.

This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development.

The summit will shed light on current challenges, best practices and the inside view of the future of Companion Diagnostics. We will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in Companion Diagnostics landscape.

It is an honor and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna upcoming October!

Key Practical Learning Points of the Summit:

  • Emerging tools and discoveries to advance Companion Diagnostics (CDx) adoption
  • CDx, complimentary diagnostics (CoDx), and multiplexed CDx for precisely targeted population groups
  • Optimised drug & diagnostics co-development road map
  • Efficient regulation, reimbursement, & partnerships within the CDx landscape for oncology and beyond

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Scientists, Chemists, Engineers and Fellows specialising in:

  • Companion Diagnostics
  • Molecular Diagnostics
  • Personalised Healthcare
  • Biomarkers
  • Medical Sciences
  • Experimental Medicine
  • Translational Medicine
  • Clinical Development
  • Clinical Trials
  • Regulatory
  • Commercialisation
  • Market Access
  • Payers
  • Patient Advocates
  • Insurers
  • Genomics
  • Immunology
  • Oncology
  • Non-oncology
  • Rare Diseases
  • Drug Development
  • Research
Speakers
Sponsors
Media partners
Partners

Previous Year Attendees

  • Diaxonhit,
    CEO & President

  • Healthcare Strategies,
    Founder

  • Astrazeneca,
    Executive Director & Lead of companion diagnostics

  • Leica Biosystems,
    Vice President

  • Biocartis,
    VP of Business Development

  • Almac,
    VP, Bioinformatics and Biostatistics

  • Sysmex Inostics GmbH,
    Director of Pharmaceutical Sales & Technology

  • Roche,
    Vice President, Clinical Operations

  • Roche,
    VP International Business Leader – CDx

  • R-Biopharm AG, Darmstadt,
    Vice President Companion Diagnostics

  • Integrated Medicines Ltd,
    Managing Director

  • Hologic,
    Molecular Genetic Services Manager

  • Glyconics Limited,
    Chief Executive Officer

  • Agilent Technologies,
    Global Commercial Director CDx

  • Merck KGaA,
    Associate Director - Global Business Development

  • Randox Laboratories,
    Head of Biomarker Services - Biosciences

  • Randox Laboratories,
    Marketing Manager -Biosciences

  • Randox Laboratories,
    Project Manager

  • Medac GmbH,
    Director of Companion Diagnostics

  • Medac GmbH,
    Global Portfolio & Alliance Manager

  • IMMUDEX,
    CEO

  • IMMUDEX,
    COO

  • Atlas Genetics Ltd.,
    R&D Director

  • Siemens Healthcare,
    Head of Global & Scientific Marketing

  • Crown Bioscience Inc.,
    Director of Marketing

  • Tecan Trading AG,
    Head Market Development

  • ImmunID,
    CEO

  • Thermo Fisher Scientific,
    Director, Business Development Diagnostics Partnering

  • Exosome Diagnostics GmbH,
    Vice President Product Development

  • Pierre Fabre,
    Project Leader

  • Farmavita Regulanet d.o.o,
    Media Partner / Managing Director

  • WiCON,
    Media Partner / China Representative

  • Medix Biochemica,
    R&D Manager, Diagnostics tests

  • Biotype Innovation GmbH,
    General Manager

  • Humedics GmbH,
    CEO

  • Novacyt S.A.,
    Sales & Marketing Manager

  • Centogene AG,
    CEO

  • Centogene AG,
    Senior Director of Quality Management

  • bioMérieux,
    R&D director

  • Glycotope GmbH,
    Manager Preclinical Pharmacology&ADG

  • Molecular Health GmbH,
    Key Account Manager Kliniken Clinics/Onco

  • Genefron Ltd,
    CEO

  • Roche Diagnostics International,
    Life Science Alliances

  • Roche Diagnostics GmbH,
    Life Science Alliance EMEA/LATAM

  • Pierre Fabre Pharmaceuticals,
    VP Translational Medicine

  • Roche Diagnostics,
    International Product Manager Companion Diagnostics

  • Thermo Fisher Scientific,
    Director, Business Development Diagnostics Partnering

  • Sysmex Inostics,
    VP & Managing Director, Global Commercial Operations

  • R-Biopharm AG,
    Director Early Development Companion Diagnostics

  • Sophia Genetics,
    VP Business Development

  • Sophia Genetics,
    Sales & Business Development Manager Pharma Markets

  • Merck,
    Associate Director, Global Regulatory Affairs Companion Diagnostics

  • Teva Pharmaceuticals,
    Global Head, Diagnostics & Personalized Medicine

  • QIAGEN,
    Director Companion Diagnostic Commercialization

  • Siemens Healthineers,
    Director Business Development Molecular Services

  • Horizon Discovery Ltd,
    Associate Director Business Development, Diagnostics

  • Hologic,
    Biomarker Services Manager

  • Integrated Medicines Ltd,
    Managing Director

  • numares AG,
    President & Chief Operating Officer

  • numares AG,
    Marketing Manager

  • Medac,
    Director Companion Diagnostics

  • Boehringer-ingelheim,
    Project Leader R&D

  • Roche,
    Head of Licenzing and Senior Director of CDx

  • Interlux,
    Application Specialist

  • Thermo Fisher Scientific,
    Head of Bussines Development

  • Thermo Fisher Scientific,
    Associate Director

  • Alere,
    EME Marketing Director - Infectious disease

  • GANYMED Pharmaceuticals AG,
    Regulatory Affairs Manager

  • Oxford Biodynamics,
    Chief Scientific Officer

  • Oxford Biodynamics,
    Business Development Director

  • Helsinn Healthcare,
    Dep.Director

  • MDQuest LTD,
    CEO, Business Development Consultant

  • Sanquin,
    Business Development Manager

  • Sanquin,
    Head of Marketing

  • Illumina,
    Director, Business Development

  • Illumina,
    Director, Business Development

  • Bio-Rad,
    Marketing Workflow Manager Genomics

  • Bio-Rad,
    Marketing Manager

  • Biontech AG,
    Director, Business Development

  • Sysmex Inostics GmbH,
    Pharma Key Account Manager Europe

  • Sysmex Inostics GmbH,
    Senior Product Manager

  • Roche,
    International Manager Life Science Alliances EMEA-LATAM

  • Medixbiochemica,
    R&D Manager, Diagnostics tests

  • AgPlus Diagnostics Ltd,
    Business Development Manager

  • LEO-Pharma,
    Senior Project Manager Research Projects

  • Abcam,
    Vice President, Diagnostics and Licencing

  • Sanofi,
    Global Head of Translational Medicine Early Development